Supplier News

Sep 28, 2018
By BioPharm International Editors
A collaboration using Pall’s bioprocessing technology in G-CON’s PODs enables flexible continuous bioprocessing and viral vector facility solutions.
Sep 28, 2018
By BioPharm International Editors
New software tools by Tecan, a provider of automated laboratory instruments and solutions, complement each other to enhance process monitoring of its liquid-handling platforms.
Sep 28, 2018
By BioPharm International Editors
The companies collaborated to launch a new cell-based profiling service for biochemical assay.
Sep 28, 2018
By BioPharm International Editors
Specialist biopharmaceutical company, Alvotech, has announced receipt of a manufacturing license from the Icelandic Medicines Agency, applying to its biopharmaceutical facility based in Reykjavik, Iceland.
Sep 27, 2018
By BioPharm International Editors
The sterile-manufacturing contract development manufacturing organization is approved by FDA for viral vector manufacturing fill/finish processing at its biologics facility in Scotland, UK.
Sep 27, 2018
By BioPharm International Editors
GE Healthcare, Cobra Biologics, and the Centre for Process Innovation (CPI) have entered into a collaboration to advance manufacturing of adeno-associated virus vectors for gene therapy.
Sep 21, 2018
By BioPharm International Editors
Research by Thermo Fisher Scientific and LumaCyte suggests that LumaCyte's Radiance instrument offers the ability to rapidly analyze viral vaccines to speed development and production and ensure their effectiveness.
Sep 20, 2018
By BioPharm International Editors
The company will be presenting at CPhI Worldwide on Oct. 11, 2018.
Sep 20, 2018
By BioPharm International Editors
The contract development and manufacturing organization expanded its analytical chemistry suite and added a new office in Boston, MA.
Sep 20, 2018
By BioPharm International Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
native1_300x100
lorem ipsum